5 Best Stocks Under $15

3. Roivant Sciences Ltd. (NYSE:ROIV)

Number of Investors In Q1 2023: 43

Roivant Sciences Ltd. (NYSE:ROIV) is a biotechnology firm that develops treatments for dermatitis, Crohn’s Disease, and other immune system diseases. Analysts are quite optimistic about the stock, rating the shares a Strong Buy on average and penciling in a rough $5 upside.

By the end of 2023’s first quarter, 43 of the 943 hedge funds part of Insider Monkey’s database had held Roivant Sciences Ltd. (NYSE:ROIV)’s shares. Daniel Gold’s QVT Financial is the largest investor with a $904 million stake.

Follow Roivant Sciences Ltd.